Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.
Open | $15.010 |
Close | - |
Volume / Avg. | 7.626K / 700.060K |
Day Range | 14.980 - 15.090 |
52 Wk Range | 11.370 - 16.865 |
Market Cap | $954.100M |
P/E Ratio | 6.814 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 29.49% |
Days to Cover | 19.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Innoviva (NASDAQ: INVA) through any online brokerage.
Other companies in Innoviva’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for Innoviva (NASDAQ: INVA) was reported by EF Hutton on Wednesday, May 10, 2023. The analyst firm set a price target for 22.50 expecting INVA to rise to within 12 months (a possible 49.11% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Innoviva (NASDAQ: INVA) is $15.09 last updated Today at April 26, 2024 at 9:47 AM EDT.
There are no upcoming dividends for Innoviva.
Innoviva’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Innoviva.
Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.